Persistent emergence of dengue

Emerging Infectious Diseases

Volumn 11, Issue 5, 2005, Pages 738-739

  Calisher, Charles H ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE;

CAUSE OF DEATH; DENGUE; DENGUE VIRUS; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HOST; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; MORTALITY; MOSQUITO; NOTE; PARASITE VECTOR; PERSISTENT INFECTION; PREVALENCE; SYMPTOMATOLOGY; VACCINE PRODUCTION; VIREMIA; VIRUS TRANSMISSION; VIRUS VIRULENCE;

EID: 17844403775     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1105.050195     Document Type: Note

References (4)

1. Halstead SB, O'Rourke EJ. Dengue viruses and mononuclear phagocytes. 1. Infection enhancement by non-neutralizing antibody. J Exp Med. 1977;146:201-17.
2. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239:476-81.
3. Mongkolsapaya J, Dejnirattisai W, Xu X, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med. 2003;9:921-7.
4. Guirakhoo F, Pugachev K, Zhang Z, Myers G, Levenbook I, Draper K, et al. Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates. J Virol. 2004;78:4761-75.